Exact Sciences Corp (NAS:EXAS)
$ 54.495 -0.225 (-0.41%) Market Cap: 10.09 Bil Enterprise Value: 11.79 Bil PE Ratio: 0 PB Ratio: 3.14 GF Score: 80/100

Exact Sciences Corp at Jefferies Virtual London Healthcare Conference Transcript

Nov 18, 2020 / 07:55PM GMT
Release Date Price: $112.36 (-2.84%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

All right. Good afternoon. Thanks, everybody, for joining us on the second day of Jefferies 2020 Virtual London Healthcare Conference. I'm Brandon Couillard. I cover the tools and diagnostics space here. It is my great pleasure to have Exact Sciences with us at the conference again this year. And in the virtual format, very happy to have CEO, Kevin Conroy; as well as CFO, Jeff Elliott. Thank you both for being here.

For those tuning into the webcast, please feel free to e-mail me any questions that you might have, and I'll do my best to work them in. Before we get started, Kevin, I'd be remiss to perhaps not acknowledge the recent passing of Dr. Ahlquist. I know he was a founding member of the team. I know he was a close friend of yours and everyone there at Exact and he will be missed. So our regards to him...

Kevin T. Conroy
Exact Sciences Corporation - Chairman of the Board, President & CEO

Thank you very much, Brandon. That's really decent of you, and we will miss Dave.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot